Institute of Human Virology,
Nigeria
Research Article
Preparing for HIV Vaccine Trials in Nigeria: Building the Capacity of the Community and National Coordinating, Regulatory and Ethical Bodies
Author(s): Evaezi Okpokoro, Sophia Osawe, Pam Datong, Aminu Yakubu, Morenike Ukpong, Paul Orhii, John Idoko, Patrick Dakum, Gary Garber and Alash’le AbimikuEvaezi Okpokoro, Sophia Osawe, Pam Datong, Aminu Yakubu, Morenike Ukpong, Paul Orhii, John Idoko, Patrick Dakum, Gary Garber and Alash’le Abimiku
Background: There is paucity of high-level clinical trials in Nigeria for several reasons, which include: lack of trained investigators and mentorship in the implementation of Clinical trials at international standard; inadequate investment and trained regulatory agencies to provide oversight. Therefore, the need for capacity of the national coordinating agencies (NCA); the investigative team, supporting research laboratory and the community to be developed in preparation for future HIV prevention trials including vaccine trials.
Method: In collaboration with the University of Ottawa, three regulatory agencies (NAFDAC -National Agency for Food and Drug Administration Control, NHREC- National Health Research Ethics Committee and NACA-National Agency for Control of AIDS) were identified for capacity building. We developed a phase IIB mock clinical trial model for the purpose of .. Read More»
DOI:
10.4172/2155-6113.1000260
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report